GlaxoSmithKline

GSK To Boost Spending Power Of Pharma Business Post Break-up

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...

GSK's Consumer Healthcare Business Posts Third-Quarter Growth

The consumer healthcare division of GlaxoSmithKline, which includes brands including Panadol and Aquafresh, has posted £2.5 billion (€2.9 billio...

GSK, Pfizer Looking To Realise Cost Savings Of £500m Per Annum From Tie-Up

GlaxoSmithKline has announced the completion of its tie-up with Pfizer's consumer health portfolio, adding that the joint venture is expected to realise an...

Turnover In GSK's Consumer Healthcare Division Up 5% In Q2

GlaxoSmithKline has posted a 5% growth in turnover in its consumer healthcare division, to £1.9 billion (€2.13 billion), in the second...

GSK Kicks Off Sale Of €1.1bn Consumer Health Brands: Reports

GlaxoSmithKline (GSK) has kicked off the sale of a number of consumer health brands as it seeks to raise about £1 billion (€1.13 billion) before...

GlaxoSmithKline Chairman Hampton To Step Down

GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, Britain's biggest drugmaker announced on Mon...

GSK Beats Q3 Forecasts, Nudges Up Guidance

Strong demand for a new shingles vaccine Shingrix helped pharmaceutical firm GlaxoSmithKline to post a better-than-expected 14% rise in third-quarter earni...

GSK Seeks Mid-Sept Bids For $4 Billion Indian Horlicks Unit

GlaxoSmithKline is seeking initial bids by mid-September for its India-focussed Horlicks health nutrition business, which is expected to fetch more than $4...

Subscribe Today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Enjoy unlimited digital access for 30 days

Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Get the app today!

GlaxoSmithKline

GSK To Boost Spending Power Of Pharma Business Post Break-up

GSK's Consumer Healthcare Business Posts Third-Quarter Growth

GSK, Pfizer Looking To Realise Cost Savings Of £500m Per Annum From Tie-Up

Turnover In GSK's Consumer Healthcare Division Up 5% In Q2

GSK Kicks Off Sale Of €1.1bn Consumer Health Brands: Reports

GlaxoSmithKline Chairman Hampton To Step Down

GSK Beats Q3 Forecasts, Nudges Up Guidance

GSK Seeks Mid-Sept Bids For $4 Billion Indian Horlicks Unit

GlaxoSmithKline Appoints Mackay As New CFO

Coca-Cola Among Firms Mulling Horlicks Purchase: Reports

GSK Rings In More Change As CFO Heads For Exit In 2019

GlaxoSmithKline Announces 'Strategic Review' Of Horlicks Brand

Glaxo To Buy Novartis Consumer Venture Stake For $13 Billion

GSK's Boss Looks Ready To Loosen The Straitjacket: Gadfly

Glaxo Withdraws From Bidding For Pfizer Consumer-Health Unit